文献速递主动脉疾病内脏/肾动脉与血管畸形

夹层与急性主动脉损伤行TEVAR时覆盖腹腔干与更差结局无关

Celiac Artery Coverage During TEVAR for Dissection and Acute Aortic Injury is Not Associated with Worse Outcomes.
PubMed 文献 · Ann Vasc Surg · 2022-12-15

基于血管质量倡议数据库2012至2020年8265例TEVAR患者,142例(1.7%)术中覆盖腹腔干。动脉瘤病患者覆盖腹腔干与住院死亡、30天死亡、术后并发症及肠道并发症升高相关,风险校正后仍显著;夹层或创伤患者中覆盖腹腔干与未覆盖者结局无差异。

要点

  • 动脉瘤病TEVAR覆盖腹腔干与住院死亡(16% vs 5%)、30天死亡(33% vs 23%)及并发症升高相关。
  • 风险校正后动脉瘤病覆盖腹腔干仍预测更差结局:住院死亡OR=3.6(CI 1.8-6.9)。
  • 夹层或创伤患者TEVAR覆盖腹腔干与未覆盖者结局无差异。

核心结论

  • 动脉瘤病患者TEVAR覆盖腹腔干与术后并发症、死亡显著增加及总生存降低相关。
  • 夹层或急性/创伤性主动脉病变患者TEVAR覆盖腹腔干并不预示更差结局。

研究设计与样本

  • 使用血管质量倡议数据库识别2012至2020年所有接受TEVAR的患者,按基础病理(动脉瘤、夹层或急性/创伤)分类。
  • 排除内移植物部署于主动脉6区以远或术前/术中行腹腔干血运重建的患者。
  • 对3组进行单因素、回归和Kaplan-Meier分析,聚焦术后并发症和生存。
  • 研究期间8年共8265例患者接受TEVAR,其中142例(1.7%)在索引术中覆盖腹腔干。

主要发现

  • 覆盖腹腔干的患者中,夹层占1.2%,动脉瘤占1.3%,创伤占0.7%。
  • 未校正分析中,动脉瘤病TEVAR覆盖腹腔干与住院死亡(16% vs 5%,P < 0.001)、30天死亡(33% vs 23%,P = 0.029)、任何术后并发症(排除死亡)(42% vs 25%,P < 0.001)及术后肠道并发症(3% vs 0.7%,P = 0.003)增加相关。
  • 单因素分析中,夹层或创伤患者TEVAR覆盖腹腔干与未覆盖者结局无差异。
  • 风险校正后,动脉瘤病患者覆盖腹腔干仍预测更差术后结局:住院死亡(OR=3.6,CI 1.8-6.9)、30天死亡(OR=1.6,CI 1.0-2.4)、任何术后并发症(OR 2.2,CI 1.4-3.5)及肠道特异性术后并发症(OR 3.3,CI 1.0-10.8)。
  • 多因素分析中,夹层或创伤患者TEVAR覆盖腹腔干与未覆盖者结局无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have previously identified increased morbidity and mortality with celiac artery coverage during thoracic endovascular aortic repair (TEVAR) for aneurysmal disease. This study aimed to delineate the risks associated with celiac artery coverage in all patients undergoing TEVAR for dissection, trauma, or aneurysmal disease. METHODS: Using the Vascular Quality Initiative database, we identified all patients undergoing TEVAR from 2012 to 2020 and categorized them based on the underlying pathology (aneurysm, dissection, or acute/trauma). Patients were excluded if their endograft was deployed distal to aortic zone 6 or if they had any preoperative/operative celiac revascularization procedure. Univariate, regression, and Kaplan-Meier analysis were performed for all 3 groups, focusing on postoperative complications and survival. RESULTS: There were 8,265 patients who underwent TEVAR over the 8-year study period with 142 (1.7%) having celiac artery coverage during their index procedure. Of those patients, the celiac artery was covered during TEVAR in 1.2% of patients with dissection, 1.3% with aneurysm, and 0.7% with trauma. On unadjusted analysis, celiac artery coverage in TEVAR for aneurysmal disease was associated with increased in-hospital mortality (16% vs. 5%, P < 0.001), 30-day mortality (33% vs. 23%, P = 0.029), any postoperative complication (excluding death) (42% vs. 25%, P < 0.001), and postoperative bowel complication (3% vs. 0.7%, P = 0.003). There were no differences in outcomes for patients treated with celiac coverage versus those without celiac coverage during TEVAR for dissection or trauma on univariate analysis. After risk adjustment, celiac artery coverage remained predictive of worse postoperative outcomes in patients with aneurysmal disease: in-hospital mortality (odds ratio [OR] = 3.6, confidence interval [CI] 1.8-6.9), 30-day death (OR = 1.6, CI 1.0-2.4), any postoperative complication (OR 2.2, CI 1.4-3.5), and bowel-specific postoperative complication (3.3, CI 1.0-10.8). There were no differences in patient outcomes for those treated with celiac coverage versus those without celiac coverage during TEVAR for dissection or trauma on multivariate analysis. Kaplan-Meier curves show a significant difference in overall survival based on pathology, specifically lower survival rates for patients with celiac coverage treated for aneurysmal disease. Cox regression analysis showed that celiac artery coverage for aneurysmal disease was associated with significantly increased hazard ratio affecting overall survival (hazard ratio = 2.6, P < 0.001), but there was no impact on survival in patients who underwent TEVAR with celiac coverage for dissection or trauma. CONCLUSIONS: Celiac artery coverage for patients with aneurysmal disease was correlated with a significant increase in postoperative morbidity, mortality, and lowers overall survival. However, for patients with dissection or acute/traumatic aortic pathology, celiac artery coverage does not portend worse outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tanious A, Lee S, Boitano LT, et al. Celiac Artery Coverage During TEVAR for Dissection and Acute Aortic Injury is Not Associated with Worse Outcomes. Ann Vasc Surg. 2022. PMID: 36529296. doi:10.1016/j.avsg.2022.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。